Escalas en Neurología - Sociedade Galega de Neuroloxia

11-ESCALAS (183-224) 3/6/08 11:40 Página 223
TRASTORNOS DEL MOVIMIENTO. I. ENFERMEDAD DE PARKINSON Y PARKINSONISMOS
Mazure, C. M., Cellar, J. S., Bowers, M. B. Jr., Nelson, J. C., Takeshita, J., y Zigun, B. 1995,
«Assessment of extrapyramidal symptoms during acute neuroleptic treatment», J Clin
Psychiatry, 56: 94-100.
McDoweIl, E., Lee, J. E., Swift, T., Sweet, R. D., Ogsbury, J. S., y KessIer, J. T. 1970, «Treatment
of Parkinsons syndrome with L dihydroxyiphenylalanine levadopal», Ann Intern Med,
72: 29-35.
Mitchell, S. L., Harper, Ü. W., Lau, A., y Bhalla, R. 2000, «Patterns of outcome measurement
in Parkinson ‘s disease clinical trials», Neuroepidemiology, 19: 1000-1008.
Montgomery, G. K., Reynolds, N. C, Jr., y Warren, R. M. 1985, «Qualitative assessment of
Parkinson’s disease: Study of reliability and data reduction with an abbreviated Columbio
Scale», Clin Neuropharmacol, 8; 83-92.
Montgomery, G. K., y Reynolds, N. C., Jr. 1990, «Compliance, reliability, and validity of selfmonitoring
for physical disturbances of Parkinson’s disease. The Parkinson’s Symptom
Diary», J Nerv Ment Dis,178: 636-641.
Nilsson, F. M., Hansen, B. L., Buchel, C., Gattaz, W. F., y Gerlach, J. 1996, «Digital movement
analysis, a new objective method of measuring tardive dyskinesia and drug-induced
parkinsonian tremor: Acceptability, reliability and validity», Eur Arch Psychiatry Clin Neurosci,
246: 71-77.
Pedersen, S. W., y Oberg, B. 1993, «Dynannc strength in Parkinsons disease. Quantitative
measurements following withdrawal of medication», Eur Neurol, 33: 97-102.
Peto, V., Jenkinson, C., Fitzpatrick, R., y Greenhall, R. 1995, «The development and validation
of a short mensure offunctioning and well being for individuals wilh Parkinsons
disease», Qual Life Res, 4: 241-248.
Pineda, D. A., y Sánchez, J. L. 1998, «Un instrumento para la evaluación cuantitativa de los
síntomas en la enfermedad de Parkinson idiopática definida», Rev Neurol, 27: 932-939.
Pinter, M. M., Helscher, R. J., Nasel, C. O., RiedI, E., y Schnaberth, G. 1992, «Quantification
of motor deficit in Parkinsons disease with a motor performance test series», J Neural
Transm Park Dis Dement Sect, 4: 131-141.
Podsiadlo, D., y Richardson, S. 1991, «Test «up and go»», J Am Geriatr Soc, 39: 142-148.
Porta-Etessam, et al. 1997, «Análisis de Bradicinesia», Neurología, 10: 452.
Prochazka, A., Bennett, D. J., Stephens, M. J. et al. 1997, Measurement of rigidity in Parkinsons
disease», Mov Disord, 12: 24-32.
Rabey, J. M., Bass, H., Bonuccelli, U. et al. «A validation of the Short Parkinson’s Evaluation
Scale: A new friendly scale for the evaluation of Parkinson’s disease in clinical drug
trials», Clin Neuropharmacol, 20: 322-337.
Richards, M., Marder, K., Cote, L., y Mayeux, R. 1994, «Interrater reliability of the Unified
Parkinson’s Disease Rating Scale motor examination», Mov Disord, 9: 89-91.
Rocca, W. A., Maraganore, D. M., McDonnell, S. K., y Schaid, D. J. 1998, «Validation of a telephone
questionnaire for Parkinson’s disease», J Clin Epidemiol, 51: 517-523.
Schenkman, M., Cutson, T. M., Kuchibhatla. M., et al. 1997, «Reliability of impairment and physical
performance mensures for persons with Parkinson ‘s disease», Phys Ther, 77: 19-27.
Schrag, A., Selai, C., Jahanshahi, M., y Quinn, N. P. 2000, «The EQ-5D: A generic quality of
life mensure is a useful instrument to mensure quality of life in patients with Parkinson’s
disease», J Neurol Neurosurg Psychiatry, 69: 67-73.
Schwab, R. S., England, A. C. 1969, «Projection technique for evaluating surgery in Parkinsons
disease», en: Cillinghamn, E. J. et al. (eds.), Third Symposium in Parkinson’s Disease,
Livingston, Edinburgh, pp. 152-157.
Siesling, S., Zwinderman, A. H., van Vugt, J. P., Kieburtz, K., y Roos, R. A. 1997, «A shortened
version of the motor section of the Unified Huntingtons Disease Rating Scale»,
Mov Disord, 12: 229-234.
� 223 �